# Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their Parents

> **NCT01182857** · — · WITHDRAWN · sponsor: **National Human Genome Research Institute (NHGRI)**

## Conditions studied

- ADA-SCID

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01182857
- **Lead sponsor:** National Human Genome Research Institute (NHGRI)
- **Sponsor class:** NIH
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2010-08-05
- **Primary completion:** —
- **Final completion:** 2014-09-25
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2019-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01182857

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01182857, "Quality of Life and Neuropsychiatric Sequelae in Patients Treated With Gene Therapy for ADA-SCID and in Their Parents". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01182857. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*